← Back to Search

Non-invasive Brain Stimulation

rTMS for AUD+mTBI (TMS_AUD+mTBI Trial)

Phase 2
Waitlist Available
Led By Amy A Herrold, PhD BA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 22 through 65
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately after last/10th rtms session, and 1 day, 1 week, and 1 month follow-up
Awards & highlights

TMS_AUD+mTBI Trial Summary

This trial is testing whether a treatment called repetitive transcranial magnetic stimulation (rTMS) can help reduce alcohol craving in veterans with mild traumatic brain injury and/or post-traumatic stress disorder.

Who is the study for?
This trial is for English-speaking Veterans aged 22-65 with alcohol use disorder (AUD) and mild traumatic brain injury or PTSD. They must pass an MRI safety screening, have specific AUDIT-C scores, and not be in severe alcohol withdrawal. Exclusions include severe TBI, psychotic disorders, seizure history, certain medication use, substance dependence other than alcohol, recent mild TBI or surgery involving the heart/brain vessels.Check my eligibility
What is being tested?
The study tests repetitive Transcranial Magnetic Stimulation (rTMS) to reduce alcohol cravings in Veterans with AUD plus mTBI/PTSD. It's a randomized controlled trial where half receive real rTMS and half get placebo over two weeks (10 sessions). Follow-up calls assess craving levels post-treatment.See study design
What are the potential side effects?
While not specified here, common side effects of rTMS may include headache, scalp discomfort at the treatment site during stimulation sessions; rare risks involve seizures or hearing loss if ear protection isn't used.

TMS_AUD+mTBI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 22 and 65 years old.

TMS_AUD+mTBI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately after last/10th rtms session, and 1 day, 1 week, and 1 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately after last/10th rtms session, and 1 day, 1 week, and 1 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Penn Alcohol Craving Scale Change
Total Adverse Event Frequency
Total rTMS Sessions Completed

TMS_AUD+mTBI Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: activeActive Control1 Intervention
active rTMS
Group II: placeboPlacebo Group1 Intervention
placebo rTMS

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,602 Total Patients Enrolled
41 Trials studying Alcoholism
6,475 Patients Enrolled for Alcoholism
Amy A Herrold, PhD BAPrincipal InvestigatorEdward Hines Jr. VA Hospital, Hines, IL
2 Previous Clinical Trials
119 Total Patients Enrolled
1 Trials studying Alcoholism
100 Patients Enrolled for Alcoholism

Media Library

Repetitive Transcranial Magnetic Stimulation (rTMS) (Non-invasive Brain Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT03995173 — Phase 2
Alcoholism Research Study Groups: active, placebo
Alcoholism Clinical Trial 2023: Repetitive Transcranial Magnetic Stimulation (rTMS) Highlights & Side Effects. Trial Name: NCT03995173 — Phase 2
Repetitive Transcranial Magnetic Stimulation (rTMS) (Non-invasive Brain Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03995173 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the criteria for eligibility to participate in this research?

"The requirements for inclusion in this trial include having an alcohol use disorder and being between the ages of 22 and 65. The total amount of participants sought after is 1 individual."

Answered by AI

Are there any openings for participants in this experiment at present?

"The records on clinicaltrials.gov suggest that this trial is no longer actively recruiting, last being updated on April 27th 2022 since its inception in March of 2019. However, over 1684 other studies are currently looking for participants at this time."

Answered by AI

Can active be utilized safely by individuals?

"After assessing the evidence, our team at Power has assigned an assessment score of 2 to active, as it is currently undergoing Phase 2 trials where safety has been partially established but efficacy remains unconfirmed."

Answered by AI

Is geriatric participation accepted in this medical experiment?

"This study is open to participants aged 22 or older and below the age of 65."

Answered by AI

Who else is applying?

What site did they apply to?
Edward Hines Jr. VA Hospital, Hines, IL
What portion of applicants met pre-screening criteria?
Met criteria
~0 spots leftby Nov 2024